Tumorigenic WAP-T mouse mammary carcinoma cells: A model for a self-reproducing homeostatic cancer cell system

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Wegwitz, Florian ^a   Kluth, Mark Andreas ^a   Mänz, Claudia ^a   Otto, Benjamin ^b   Gruner, Katharina ^a   Heinlein, Christina ^a,c   Kühl, Marion ^a   Warnecke, Gabriele ^a   Schumacher, Udo ^b   Deppert, Wolfgang ^a   Tolstonog, Genrich V ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA6 INTEGRIN; CD24A ANTIGEN; CD61 ANTIGEN; CELL SURFACE MARKER; CELL SURFACE PROTEIN; CYTOKERATIN; EPITHELIAL CELL ADHESION MOLECULE; LYMPHOCYTE ANTIGEN; PROTEIN THY1; STEM CELL ANTIGEN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST2; UNCLASSIFIED DRUG; VIMENTIN; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER STEM CELL; CANCER TISSUE; CARCINOGENIC ACTIVITY; CELL CLONE; CELL COMPOSITION; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL POPULATION; CELL RENEWAL; CELL SELECTION; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HISTOLOGY; HOMEOSTASIS; MESENCHYME; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ANIMAL; BIOLOGICAL MODEL; CELL COMMUNICATION; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MESODERM; METABOLISM; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE;

MUS;

ANIMALS; BIOLOGICAL MARKERS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CLONE CELLS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HOMEOSTASIS; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MESODERM; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; PHENOTYPE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 77957879525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012103     Document Type: Article

References (80)

1. Rubin H (2007) Ordered heterogeneity and its decline in cancer and aging. Adv Cancer Res 98: 117-147.
2. Dick JE (2008) Stem cell concepts renew cancer research. Blood 112: 4793-4807.
3. Ward RJ, Dirks PB (2007) Cancer Stem Cells: At the Headwaters of Tumor Development. Annu Rev Pathol 2: 175-189.
4. Lobo NA, Shimono Y, Qian D, Clarke MF (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699.
5. Nowell PC (1986) Mechanisms of tumor progression. Cancer Res 46: 2203-2207.
6. Lotem J, Sachs L (2006) Epigenetics and the plasticity of differentiation in normal and cancer stem cells. Oncogene 25: 7663-7672.
7. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
8. Shackleton M, Quintana E, Fearon ER, Morrison SJ (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138: 822-829.
9. Gupta PB, Chaffer CL, Weinberg RA (2009) Cancer stem cells: mirage or reality? Nat Med 15: 1010-1012.
10. Lander AD (2009) The 'stem cell' concept: is it holding us back? J Biol 8: 70.
11. Klymkowsky MW, Savagner P (2009) Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol 174: 1588-1593.
12. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
13. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
14. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
15. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e2888.
16. Heinlein C, Krepulat F, Lohler J, Speidel D, Deppert W, et al. (2008) Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis. Int J Cancer 122: 1701-1709.
17. Jannasch K, Dullin C, Heinlein C, Krepulat F, Wegwitz F, et al. (2009) Detection of different tumor growth kinetics in single transgenic mice with oncogene-induced mammary carcinomas by flat-panel volume computed tomography. Int J Cancer 125: 62-70.
18. Krepulat F, Lohler J, Heinlein C, Hermannstadter A, Tolstonog GV, et al. (2005) Epigenetic mechanisms affect mutant p53 transgene expression in WAPmutp53 transgenic mice. Oncogene 24: 4645-4659.
19. Schulze-Garg C, Lohler J, Gocht A, Deppert W (2000) A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland. Oncogene 19: 1028-1037.
20. Tzeng YJ, Guhl E, Graessmann M, Graessmann A (1993) Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene. Oncogene 8: 1965-1971.
21. Robinson GW, McKnight RA, Smith GH, Hennighausen L (1995) Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121: 2079-2090.
22. Herschkowitz JI, He X, Fan C, Perou CM (2008) The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas. Breast Cancer Res 10: R75.
23. Manie E, Vincent-Salomon A, Lehmann-Che J, Pierron G, Turpin E, et al. (2009) High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors. Cancer Res 69: 663-671.
24. Li Z, Tognon CE, Godinho FJ, Yasaitis L, Hock H, et al. (2007) ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 12: 542-558.
25. Thompson EW, Newgreen DF, Tarin D (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995.
26. Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.
27. Shamir R, Maron-Katz A, Tanay A, Linhart C, Steinfeld I, et al. (2005) EXPANDER-an integrative program suite for microarray data analysis. BMC Bioinformatics 6: 232.
28. Bassuk AG, Barton KP, Anandappa RT, Lu MM, Leiden JM (1998) Expression pattern of the Ets-related transcription factor Elf-1. Mol Med 4: 392-401.
29. Kendrick H, Regan JL, Magnay FA, Grigoriadis A, Mitsopoulos C, et al. (2008) Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 9: 591.
30. Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, et al. (2008) Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 68: 4674-4682.
31. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
32. Stingl J, Raouf A, Emerman JT, Eaves CJ (2005) Epithelial progenitors in the normal human mammary gland. J Mammary Gland Biol Neoplasia 10: 49-59.
33. Cho RW, Wang X, Diehn M, Shedden K, Chen GY, et al. (2008) Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26: 364-371.
34. Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E (2007) Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res 67: 8671-8681.
35. Vassilopoulos A, Wang RH, Petrovas C, Ambrozak D, Koup R, et al. (2008) Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells. Int J Biol Sci 4: 133-142.
36. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, et al. (2008) The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 68: 7711-7717.
37. Grange C, Lanzardo S, Cavallo F, Camussi G, Bussolati B (2008) Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice. Neoplasia 10: 1433-1443.
38. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, et al. (2008) Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14: 79-89.
39. Strickland P, Shin GC, Plump A, Tessier-Lavigne M, Hinck L (2006) Slit2 and netrin 1 act synergistically as adhesive cues to generate tubular bi-layers during ductal morphogenesis. Development 133: 823-832.
40. Greenberg JM, Thompson FY, Brooks SK, Shannon JM, Akeson AL (2004) Slit and robo expression in the developing mouse lung. Dev Dyn 230: 350-360.
41. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, et al. (2009) Hypoxiainduced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15: 35-44.
42. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
43. Galang CK, Muller WJ, Foos G, Oshima RG, Hauser CA (2004) Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J Biol Chem 279: 11281-11292.
44. Choi YS, Chakrabarti R, Escamilla-Hernandez R, Sinha S (2009) Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. Dev Biol 329: 227-241.
45. Firlej V, Ladam F, Brysbaert G, Dumont P, Fuks F, et al. (2008) Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription. J Cell Sci 121: 3393-3402.
46. Bloushtain-Qimron N, Yao J, Snyder EL, Shipitsin M, Campbell LL, et al. (2008) Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A 105: 14076-14081.
47. Zipori D (2005) The stem state: plasticity is essential, whereas self-renewal and hierarchy are optional. Stem Cells 23: 719-726.
48. Chang HH, Hemberg M, Barahona M, Ingber DE, Huang S (2008) Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 453: 544-547.
49. Kai K, Nagano O, Sugihara E, Arima Y, Sampetrean O, et al. (2009) Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model. Cancer Sci 100: 2275-2282.
50. Meyer MJ, Fleming JM, Ali MA, Pesesky MW, Ginsburg E, et al. (2009) Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines. Breast Cancer Res 11: R82.
51. Visvader JE (2009) Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 23: 2563-2577.
52. Smith GH (2005) Stem cells and mammary cancer in mice. Stem Cell Rev 1: 215-223.
53. Sun P, Yuan Y, Li A, Li B, Dai X (2010) Cytokeratin expression during mouse embryonic and early postnatal mammary gland development. Histochem Cell Biol 133: 213-221.
54. Buono KD, Robinson GW, Martin C, Shi S, Stanley P, et al. (2006) The canonical Notch/RBP-J signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy. Dev Biol 293: 565-580.
55. McCaffrey LM, Macara IG (2009) The Par3/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis. Genes Dev 23: 1450-1460.
56. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, et al. (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439: 993-997.
57. Nelson CM, Vanduijn MM, Inman JL, Fletcher DA, Bissell MJ (2006) Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 314: 298-300.
58. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, et al. (1999) Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112 Pt 24: 4615-4625.
59. Curtis SJ, Sinkevicius KW, Li D, Lau AN, Roach RR, et al. (2010) Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells. Cell Stem Cell 7: 127-133.
60. Smalley MJ, Clarke RB (2005) The mammary gland 'side population': a putative stem/progenitor cell marker? J Mammary Gland Biol Neoplasia 10: 37-47.
61. Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, et al. (2008) BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A 105: 1680-1685.
62. Dakir EL, Feigenbaum L, Linnoila RI (2008) Constitutive expression of human keratin 14 gene in mouse lung induces premalignant lesions and squamous differentiation. Carcinogenesis 29: 2377-2384.
63. Sleeman KE, Kendrick H, Robertson D, Isacke CM, Ashworth A, et al. (2007) Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 176: 19-26.
64. Lennon VA, Unger M, Dulbecco R (1978) Thy-1: a differentiation marker of potential mammary myoepithelial cells in vitro. Proc Natl Acad Sci U S A 75: 6093-6097.
65. Rudland PS, Warburton MJ, Monaghan P, Ritter MA (1982) Thy-1 antigen on normal and neoplastic rat mammary tissues: changes in location and amount of antigen during differentiation of cultured stem cells. J Natl Cancer Inst 68: 799-811.
66. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563.
67. Reiman JM, Knutson KL, Radisky DC (2010) Immune promotion of epithelialmesenchymal transition and generation of breast cancer stem cells. Cancer Res 70: 3005-3008.
68. Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, et al. (2009) Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 69: 2887-2895.
69. Cannito S, Novo E, Compagnone A, Valfre di Bonzo L, Busletta C, et al. (2008) Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 29: 2267-2278.
70. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, et al. (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10: 295-305.
71. Moen I, Oyan AM, Kalland KH, Tronstad KJ, Akslen LA, et al. (2009) Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model. PLoS One 4: e6381.
72. Huang S (2009) Reprogramming cell fates: reconciling rarity with robustness. Bioessays 31: 546-560.
73. Gumireddy K, Li A, Gimotty PA, Klein-Szanto AJ, Showe LC, et al. (2009) KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol 11: 1297-1304.
74. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
75. Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, et al. (1978) Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 38: 3174-3181.
76. Mollaaghababa R, Pavan WJ (2003) The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia. Oncogene 22: 3024-3034.
77. Hargreaves DC, Horng T, Medzhitov R (2009) Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138: 129-145.
78. Iliopoulos D, Hirsch HA, Struhl K (2009) An epigenetic switch involving NFkappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139: 693-706.
79. Smalley MJ, Titley J, O'Hare MJ (1998) Clonal characterization of mouse mammary luminal epithelial and myoepithelial cells separated by fluorescenceactivated cell sorting. In Vitro Cell Dev Biol Anim 34: 711-721.
80. Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML, et al. (1998) SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors. Oncogene 16: 2103-2114.